Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
about
Biomarkers and Targeted Therapy in Pancreatic CancerMechanistic basis and clinical relevance of the role of transforming growth factor-β in cancerA current perspective on stereotactic body radiation therapy for pancreatic cancerTGFBR1 and cancer susceptibility.Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer CachexiaPrognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis.Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer.TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in CancerClinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.Stereotactic body radiation therapy in pancreatic cancer: the new frontier.Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients.Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
P2860
Q26752755-F57FCE19-B626-464B-8618-5AEB27BC5724Q26771386-1E119833-EA3A-4114-A192-A65FC58ACBABQ28077111-C8FF354C-BF00-4423-94E1-9B938C358E5EQ33957710-F73E2191-CF14-4533-885B-6CCCBA91A3F0Q34344060-FCFB2D3D-8FBE-4FCA-8FF7-52764E280885Q35690582-56D7F99B-3372-4B54-A1B6-8FADF8054B94Q36707119-EF75BE59-FC55-49BB-AB1A-B9E6B69D8A6FQ37430812-E6281FC5-2017-4B96-8F67-25A39218DE0AQ37629557-0D94CF4C-51D7-4D5E-BAB1-72BD878CA322Q37725506-DF61A910-BC74-439F-BDD8-DE1AA9390958Q38245676-F68B4071-03BB-4988-AAA6-0EA4C099986AQ38645800-60056361-FA96-4C9E-9366-14F5CD7C87FCQ38873616-5F2070D9-0306-4366-9868-2A6C85AE842BQ40590883-2BDB1D17-1AFF-481B-94CC-C8AE3002B08FQ41621899-81D2ED8D-9796-4EAF-A712-6E1AA7A0A302Q49853764-A22A36A8-DA67-402F-8242-A9684B1B7374Q55439547-AEE6EBE0-8257-4FB9-9062-0FC35AB02926
P2860
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@en
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@nl
type
label
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@en
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@nl
prefLabel
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@en
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@nl
P2093
P2860
P1433
P1476
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
@en
P2093
Dongfeng Tan
Donghui Li
Milind Javle
Ping Chang
Xiaoqun Dong
P2860
P304
P356
10.1371/JOURNAL.PONE.0085942
P407
P577
2014-01-20T00:00:00Z